ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,647.39
0.29%
Dow Jones
40,428.81
0.54%
US Dollar vs MXN
17.7239
-0.04%
Brent Oil
83.05
-1.53%
Bitcoin
63,785.35
-1.64%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Adamis Pharmaceuticals Corporation (ADMP)

  7. Adamis Pharmaceuticals Corporation (ADMP) Noticias

ADMP

Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ADMP
FechaHoraFuenteTítuloSímboloCompañía
15/03/201915:39GlobeNewswire Inc.Adamis Pharmaceuticals Announces 2018 Financial Results and Provides Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
15/03/201915:24Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/03/201915:55Business WireAdamis Pharmaceuticals Announces FDA Acceptance for Review of the New Drug Application of Its Higher Dose Naloxone Injection ...NASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/03/201915:13Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
26/02/201917:54GlobeNewswire Inc.Adamis Provides Regulatory Update on Sublingual TadalafilNASDAQ:ADMPAdamis Pharmaceuticals Corporation
20/02/201908:00GlobeNewswire Inc.Adamis Pharmaceuticals Publishes the Rationale for a Higher Dose Naloxone Product to Counter the Current Opioid EpidemicNASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/02/201917:47Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
11/02/201909:28Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/02/201916:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
25/01/201916:08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/01/201915:18GlobeNewswire Inc.Adamis’ Commercial Partner Launches SYMJEPI™ (epinephrine) in the USNASDAQ:ADMPAdamis Pharmaceuticals Corporation
31/12/201815:02GlobeNewswire Inc.Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Naloxone Pre-Filled SyringeNASDAQ:ADMPAdamis Pharmaceuticals Corporation
28/12/201818:46GlobeNewswire Inc.Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Tadalafil Sublingual TabletNASDAQ:ADMPAdamis Pharmaceuticals Corporation
18/12/201815:05Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/12/201808:30GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update on the U.S. Launch of SYMJEPINASDAQ:ADMPAdamis Pharmaceuticals Corporation
09/11/201815:46GlobeNewswire Inc.Adamis Pharmaceuticals Announces Third Quarter 2018 Financial Results and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
09/11/201815:20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
27/09/201815:05GlobeNewswire Inc.Adamis Pharmaceuticals Receives FDA Approval for Its Lower Dose Symjepi ProductNASDAQ:ADMPAdamis Pharmaceuticals Corporation
27/08/201811:02GlobeNewswire Inc.Adamis Pharmaceuticals Provides Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
10/08/201808:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/08/201815:05GlobeNewswire Inc.Adamis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in FullNASDAQ:ADMPAdamis Pharmaceuticals Corporation
03/08/201805:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
02/08/201808:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Pricing of Public Offering of Common StockNASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/08/201815:03GlobeNewswire Inc.Adamis Pharmaceuticals Announces Proposed Public Offering of Common StockNASDAQ:ADMPAdamis Pharmaceuticals Corporation
23/07/201808:00GlobeNewswire Inc.Adamis Pharmaceuticals Adds Sublingual Erectile Dysfunction Product Candidate to its PipelineNASDAQ:ADMPAdamis Pharmaceuticals Corporation
19/07/201805:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
11/07/201815:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
09/07/201817:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/07/201819:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Distribution and Commercialization Agreement for SymjepiNASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/06/201815:48Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
 Showing the most relevant articles for your search:NASDAQ:ADMP

Su Consulta Reciente

NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
AXP
American Express
PM
XAUUSD
Gold vs US Dollar
COIN
BTCUSD
Bitcoin
SPI
SP500
S&P 500
NASDAQ
NVDA
NVIDIA
CCOM
US500
US 500
NYSE
JPM
JP Morgan Chase
USOTC
BNPQY
BNP Paribas (QX)
COIN
SOLUSD
Solana
NYSE
VZ
Verizon Communications
FX
EURMXN
Euro vs MXN
NASDAQ
AMZN
Amazon.com
NASDAQ
MSFT
Microsoft
FX
EURUSD
Euro vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados